Karyopharm Therapeutics Inc (KPTI)
1.09
+0.03
(+2.83%)
USD |
NASDAQ |
May 10, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 20:00
Karyopharm Therapeutics Shareholders Equity (Quarterly): -136.21M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -136.21M |
| September 30, 2023 | -100.40M |
| June 30, 2023 | -71.25M |
| March 31, 2023 | -45.17M |
| December 31, 2022 | -16.66M |
| September 30, 2022 | -140.28M |
| June 30, 2022 | -116.34M |
| March 31, 2022 | -83.08M |
| December 31, 2021 | -79.67M |
| September 30, 2021 | -125.98M |
| June 30, 2021 | -83.13M |
| March 31, 2021 | -39.64M |
| December 31, 2020 | 50.55M |
| September 30, 2020 | 83.77M |
| June 30, 2020 | 129.80M |
| March 31, 2020 | 166.15M |
| December 31, 2019 | 49.77M |
| September 30, 2019 | 59.87M |
| June 30, 2019 | 82.47M |
| March 31, 2019 | 121.28M |
| December 31, 2018 | 183.17M |
| September 30, 2018 | 171.08M |
| Date | Value |
|---|---|
| June 30, 2018 | 213.47M |
| March 31, 2018 | 95.53M |
| December 31, 2017 | 129.46M |
| September 30, 2017 | 141.18M |
| June 30, 2017 | 166.71M |
| March 31, 2017 | 138.36M |
| December 31, 2016 | 162.24M |
| September 30, 2016 | 166.93M |
| June 30, 2016 | 153.57M |
| March 31, 2016 | 177.04M |
| December 31, 2015 | 198.36M |
| September 30, 2015 | 220.59M |
| June 30, 2015 | 247.33M |
| March 31, 2015 | 275.52M |
| December 31, 2014 | 206.79M |
| September 30, 2014 | 227.80M |
| June 30, 2014 | 131.68M |
| March 31, 2014 | 144.10M |
| December 31, 2013 | 154.93M |
| September 30, 2013 | -47.78M |
| June 30, 2013 | 59.94M |
| December 31, 2012 | -27.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-140.28M
Minimum
Sep 2022
166.15M
Maximum
Mar 2020
-21.86M
Average
-45.17M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Geron Corp | 344.87M |
| Arbutus Biopharma Corp | 114.64M |
| Verastem Inc | 57.37M |
| Actinium Pharmaceuticals Inc | 43.86M |
| Chimerix Inc | 174.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 240.44M |
| Total Liabilities (Quarterly) | 376.64M |
| Debt to Equity Ratio | -1.255 |
| Current Ratio | 3.367 |
| Net Debt Paydown Yield | -0.21% |